Catalyst Wire Dossier Catalyst Wire Dossier

BKEMV

eculizumab-aeeB · Amgen Inc
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for BKEMV, covering 2024-05-28 to 2026-03-26. Get the full timeline:

Most recent: FDA Approved: BKEMV — Supplemental Application (Amgen Inc)

See pricing